Description of Blood Analysis:

HBeAg is a protein produced during the active replication of the Hepatitis B virus. It serves as a primary indicator of how fast the virus is multiplying in the liver cells. When this antigen is present in the blood, the person is considered highly infectious, and the risk of transmitting the virus to others (through blood or bodily fluids) is at its peak. In clinical practice, HBeAg is the “activity marker” that helps doctors decide when to start antiviral therapy and how to predict the long-term risk of liver damage.

What does the analysis represent?

• Goal: To detect the “e-antigen,” which signifies high levels of viral replication.
• Primary Application: Assessing the contagiousness of the patient, determining the phase of chronic Hepatitis B, and monitoring the response to antiviral drugs.
• Method: Chemiluminescent Immunoassay (CLIA).

Recommendations for the Test (General)

• Time: Morning blood collection is standard.
• Fasting: 8–12 hours recommended; water permitted.
• Rest: Stay calm and avoid strenuous exercise for 30 minutes before the draw.
• Specific Rules: This test is only relevant if you have already tested positive for the surface antigen (HBsAg).

What can affect the results?

• Factors Altering Levels: Pre-core mutants (strains of the virus that replicate but cannot produce HBeAg); current antiviral treatment (which suppresses replication); or the transition phase where the body begins to clear the antigen (seroconversion).

When to take the test?

• Recommendations: If you have been diagnosed with chronic Hepatitis B, during pregnancy to assess the risk of transmission to the newborn, or periodically to monitor the success of a treatment plan.
• Preparation: No specialized preparation is required beyond standard fasting protocols.

How to interpret the results? 

The evaluation of HBeAg status is complex and must be conducted exclusively by a physician. A positive result indicates a high viral load and high infectivity, but a negative result does not always mean the virus is inactive. Certain “mutant” forms of the virus can cause severe liver disease without producing HBeAg. Only a specialist can correlate this result with your HBV DNA levels and liver enzymes to provide an accurate diagnosis.

Possible further investigations

• Anti-HBe (Hepatitis B e-Antibody): To see if the body has started to fight the replication.
• HBV DNA Quantitative (PCR): To measure the exact number of viral copies.
• ALT/AST Panel: To check for active liver cell injury.
• FibroScan: To evaluate the physical state of the liver tissue.
• Consultation with a Hepatologist: For a long-term treatment strategy.

When does the next step make sense?

 If the HBeAg is positive, the next step is a detailed discussion with your doctor about starting or adjusting antiviral therapy. If it is negative while the viral load remains high, your doctor will investigate possible viral mutations. All changes to your medical management should be guided by a professional.

👉 If necessary, you can discuss the results of the analysis with a specialist, such as an gastroenterologist (Doctors – TAMC).